Working…
ClinicalTrials.gov

Exit Notice

You are about to leave ClinicalTrials.gov and go to: Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134103/

Click on the link to continue or return to ClinicalTrials.gov Home